Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis

Abstract Background and Aim Serum leucine‐rich alpha‐2 glycoprotein level has been reported to be a useful biomarker in assessing mucosal healing in patients undergoing biotherapy, where mucosal lesions caused by ulcerative colitis are difficult to assess endoscopically. However, no such reports hav...

Descripció completa

Dades bibliogràfiques

Autors principals:	Masashi Kono, Yoriaki Komeda, George Tribonias, Saki Yoshida, Kenji Nomura, Kohei Handa, Tomoyuki Nagai, Satoru Hagiwara, Shunsuke Omoto, Mamoru Takenaka, Naoshi Nishida, Naoko Tsuji, Hiroshi Kashida, Masatoshi Kudo
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2023-08-01
Col·lecció:	JGH Open
Matèries:	biotherapy‐naïve leucine‐rich alpha‐2 glycoprotein ulcerative colitis
Accés en línia:	https://doi.org/10.1002/jgh3.12953
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!